TNXP Insider Trading Activity and SEC Form 4 Filings
TNXP insider trading summary
Over the past 12 months, insiders at Tonix Pharmaceuticals Holding Corp. (TNXP) reported 6 open-market purchases worth $446K by 3 insiders and no sales on SEC Form 4. Net insider buying was $446K.
Latest TNXP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 27, 2026 | Seth Lederman | Chief Executive Officer | Buy | $28K (2,000 @ $13.79) |
| Jun 12, 2026 | Carolyn E. Taylor | Director | Buy | $15K (1,415 @ $10.55) |
| Jun 9, 2026 | Seth Lederman | Chief Executive Officer | Buy | $59K (5,000 @ $11.79) |
| Jun 8, 2026 | Richard Newcomb Stillwell | Director | Buy | $58K (5,000 @ $11.65) |
| Mar 31, 2026 | Seth Lederman | Chief Executive Officer | Buy | $63K (5,000 @ $12.62) |
| Mar 18, 2026 | Seth Lederman | Chief Executive Officer | Buy | $223K (15,000 @ $14.89) |
| Aug 21, 2025 | Carolyn E. Taylor | Director | Buy | $15K (418 @ $36.03) |
| Aug 20, 2025 | James Treco | Director | Buy | $9K (250 @ $36.00) |
| May 15, 2025 | Seth Lederman | Chief Executive Officer | Buy | $86K (4,000 @ $21.55) |
| Jun 29, 2022 | Seth Lederman | Chief Executive Officer | Buy | $34K (20,000 @ $1.71) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.